Particularities of Male Breast Cancer in the Rabat Region: A Multidimensional Approach


Authors : S. Smiti; R. Laraichi; C. Ezzouitina; K. Nouni; A. Lachgar; H. El Kacemi; T. Kebdani; K. Hassouni

Volume/Issue : Volume 10 - 2025, Issue 7 - July

Google Scholar : https://tinyurl.com/e9arypnv

Scribd : https://tinyurl.com/3r2kzznf

DOI : https://doi.org/10.38124/ijisrt/25jul320

PlumX Metrics

Semantic Scholar

ResearchGate

Google Scholar

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 30 to 40 days to display the article.

Abstract : Introduction: Male breast cancer is a rare disease, accounting for just 1% of all breast cancers. This low incidence and lack of awareness often lead to delayed diagnosis and advanced disease. In addition to its specific clinical and epidemiological features, it has a significant psychological impact, due to its feminine connotations and the stigma attached to the diagnosis.  Methods: This retrospective descriptive study analysed the clinical, epidemiological and psychosocial data of breast cancer patients. Data were collected from medical records, and from semi-structured interviews with patients.  Results: The mean age at diagnosis was 63, with most patients consulting for a retroareolar mass, but also for delayed presentation, sometimes more than 6 months. Locally advanced forms were noted. The ordeal of the disease was marked by significant psychological distress: anxiety, social isolation, body image problems and feelings of stigmatisation. Several patients said they were embarrassed to talk about their illnesses, fearing a lack of social and medical understanding.  Conclusion, Male breast cancer poses multiple problems. In addition to medical treatment, a comprehensive approach including psychological support is needed. Better information for the public and healthcare professionals would enable earlier detection and more appropriate treatment, both somatic and psychological.

References :

  1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A,et al. Statistiques mondiales sur le cancer 2020 : estimations GLOBOCAN de l'incidence et de la mortalité dans le monde pour 36 cancers dans 185 pays.CA Cancer J Clin2021;71(3):209et249.
  2. Revue des statistiques sur le cancer du SEER1975-2018. Disponible auprès de : https://seer.cancer.gov/csr/1975_2018/index.html.
  3. Konduri S, Singh M, Bobustuc G, Rovin R, Kassam A. Epide miology of male breast cancer. Breast 2020;54:8e14.
  4. Liu N, Johnson KJ, Ma CX. Male Breast Cancer: An Updated Surveillance, Epidemiology, and End Results Data Analysis. Clin Breast Cancer 2018;18(5):e997ee1002.
  5. Gradishar WJ, Moran MS, Abraham J, Aft R, Agnese D, Allison KH, et al. Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2022; 20(6):691e722.
  6. Matro JM, Li T, Cristofanilli M, Hughes ME, Ottesen RA, Weeks JC, et al. Inflammatory breast cancer management in the national comprehensive cancer network: the disease, recurrence pattern, and outcome. Clin Breast Cancer 2015; 15(1):1e7.
  7. Hassett MJ, Somerfield MR, Baker ER, Cardoso F, Kansal KJ, Kwait DC, et al. Management of Male Breast Cancer: ASCO Guideline. J Clin Oncol 2020;38(16):1849e1863.
  8. Arzanova E, Mayrosvitz HN. Male Breast Cancer: Treatment Trends, Reported Outcomes, and Suggested Recommenda tions. Cureus 2021;13(9):e18337.
  9. Giuliano AE, Edge SB, Hortobagyi GN. Eighth Edition of the AJCC Cancer Staging Manual: Breast Cancer. Ann Surg Oncol 2018;25(7):1783e1785.
  10. Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN. Breast carcinoma in men: a population-based study. Cancer. 2004;101(1):51–57. doi: 10.1002/cncr.20312. 
  11. Weiss JR, Moysich KB, Swede H. Epidemiology of male breast cancer. Cancer Epidemiol. Biomarkers Prev. 2005;14(1):20–26. 
  12. Sasco AJ, Lowenfels AB, Pasker-de J. Review article: epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors. Int J Cancer. 1993;53(4):538–549. doi: 10.1002/ijc.2910530403
  13. Thomas BD, Jimenez LM, Tiernan MC, Rosenblatt K, Stalsberg H, Stemhagen A, et al. Breast cancer in men: risk factors with hormonal implications. Am J Epidemiol. 1992;135(7):734–748. doi: 10.1093/oxfordjournals.aje.a116360. 
  14. Arnould N, Pouget O, Gharbi M, Brettes JP. Cancer du sein chez l'homme: existe-t-il une similitude avec le cancer du sein chez la femme. Gynécologie Obstétrique & Fertilité. 2006;34(5):413–419. doi: 10.1016/j.gyobfe.2006.03.014. 
  15. Sorensen HT, Fris S, Olsen JH, Thulstrup AM, Mellemikjaer L, Linet M, et al. Risk of breast cancer in men with liver cirrhosis. Am J Gastroenterol. 1998;93(2):231–233. doi: 10.1111/j.1572-0241.1998.00231.x. 
  16. Erren TC. A meta-analysis of epidemiologic studies of electric and magnetic fields and breast cancer in women and men. Bioelectromagnetics. 2001;5(Suppl 5):S105–S119. doi: 10.1002/1521-186x(2001)22:5.
  17. Yildirim E, Berberoglu U. Male breast cancer: a 22-year experience. Eur J Surg Oncol. 1998;24(6):548–552. doi: 10.1016/s0748-7983(98)93608-3. 
  18. Basham VM, Lipscombe JM, Ward JM, Gayther SA, Ponder BA, Easton DF, et al. BRCA1 and BRCA2 mutations in a population-based study of male breast cancer. Breast Cancer Res. 2002;4(1):R2. doi: 10.1186/bcr419.
  19. Stierer M, Rosen H, Weitensfelder W, et al. Male breast cancer: Austrian experience. World J. Surg. 1995;19(5):687–692. doi: 10.1007/BF00295904. 
  20. Khan HN, Blamey RW. Endocrine treatment of physiological gynaecomastia. BMJ. 2003;327(7410):301–302. doi: 10.1136/bmj.327.7410.301. 
  21. Evans GF, Anthony T, Turnage, Schumpert D, Levyk R, Aminkhan RH, et al. The diagnostic accuracy of mammography in the evaluation of male breast disease. Am J Surg. 2001;181(2):96–100. doi: 10.1016/s0002-9610(00)00571-7. 
  22. Guhan-Bilgen I, Bozkaya H, Ustun E, et al. Male breast disease: clinical, mammographic, and ultrasonographic features. Eur J Radiol. 2002;43(3):246–255. doi: 10.1016/s0720-048x(01)00483-1. 
  23. Espié M, Gorins A. Paris: Editions Eska; 2001. Le sein du normal au pathologique: état de l'art.
  24. Ottini L, Masala G, D'Amico C, Mancini B, Saieva C, Aceto G, et al. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy. Cancer Res. 2003;63(2):342–347. 
  25. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet. 1998;62(3):676–689. doi: 10.1086/301749. 
  26. Donegan WL, Redlich PN, Lang PJ, Gall MT. Carcinoma of the breast in males: a multiinstitutional survey. Cancer. 1998;83(3):498–509.  
  27. Scott-Conner CE, Jochimsen PR, Menck HR, Winchester DJ. An analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients. Surgery. 1999;126(4):775–780. 
  28. Gough DB, Donohue JH, Evans MM, Pernicone PJ, Wold LE, Naessens JM, et al. A 50-year experience of male breast cancer: is outcome changing. Surg Oncol. 1993;2(6):325–333. doi: 10.1016/0960-7404(93)90063-5. 
  29. Dong C, Hemminki K. Second primary breast cancer in men. Breast Cancer Res Treat. 2001;66(2):171–172. doi: 10.1023/a:1010639429207. 
  30. Auvinen A, Curtis RE, Ron E. Risk of subsequent cancer following breast cancer in men. J Natl Cancer Inst. 2002;94(17):1330–1332. doi: 10.1093/jnci/94.17.1330. 
  31. Perkins GH, Middleton LP, Garcia SM, et al. Male breast carcinoma: out-comes and predictors of local-regional failure in patients treated without radiation therapy. Breast Cancer Res. Treat. 2002;76:121. 
  32. Singletary SE, Allred CE, Ashley P, et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol. 2002;20(17):3628–3636. doi: 10.1200/JCO.2002.02.026. 
  33. Giordano SH, Buzdar AU, Hortobagyi GN. Breast cancer in men. Ann Intern. Med. 2002;137(8):678–687. doi: 10.7326/0003-4819-137-8-200210150-00013. µ
  34. Giordano SH, Valero V, Buzdar AU, Hortobagyi GN. Efficacy of anastrozole in male breast cancer. Am J Clin Oncol. 2002;25(3):235–237. doi: 10.1097/00000421-200206000-00006.
  35. Italiano A, Largillier A, Marcy PY, Foa C, Forrero JM, Hartmann MT, et al. Complete remission obtainde with letrozole in a man with metastatic breast cancer. RevMed Interne. 2004;25(4):323–324. doi: 10.1016/j.revmed.2003.12.006. 
  36. Farrow J, Adair F. Effect of orchiectomy on skeletal metastases from cancer of the male breast. Science. 1942;95(2478):654. doi: 10.1126/science.95.2478.654. 
  37. Dong C, Hemminki K. Second primary breast cancer in men. Breast Cancer Res Treat. 2001;66(2):171–172. doi: 10.1023/a:1010639429207. 
  38. Labrie F, Dupont A, Belanger A, Lacourciere Y, Beland L, Cusan L, et al. Complete response to combination therapy with an LHRH agonist and flutamide in metastatic male breast cancer: a case report. Clin Invest Med. 1990;13(5):275–278. 
  39. Volm Matthew D. Male breast cancer. Curr Treat Optios Oncol. 2003;4(2):159–164. doi: 10.1007/s11864-003-0017-8. 
  40. Brain K, Williams B, Iredale R, France L, Gray J. Psychological distress in men with breast cancer. J Clin Oncol. 2006;24(1):95–101. doi: 10.1200/JCO.2006.10.064. 
  41. Robinson JD, Metoyer KP, Jr, Bhayani N. Breast cancer in men: a need for psychological intervention. J clin Psychol Med Settings. 2008;15(2):134–139. doi: 10.1007/s10880-008-9106-y. 
  42. El Youbi MB, Bourhafour M, Errihani H. [Breast cancer in men in Morocco: what psycho-social impacts. Pan Afr Med J. 2013 Apr 15;14:150. French. doi: 10.11604/pamj.2013.14.150.2688. PMID: 23785555; PMCID: PMC3683524.

Introduction: Male breast cancer is a rare disease, accounting for just 1% of all breast cancers. This low incidence and lack of awareness often lead to delayed diagnosis and advanced disease. In addition to its specific clinical and epidemiological features, it has a significant psychological impact, due to its feminine connotations and the stigma attached to the diagnosis.  Methods: This retrospective descriptive study analysed the clinical, epidemiological and psychosocial data of breast cancer patients. Data were collected from medical records, and from semi-structured interviews with patients.  Results: The mean age at diagnosis was 63, with most patients consulting for a retroareolar mass, but also for delayed presentation, sometimes more than 6 months. Locally advanced forms were noted. The ordeal of the disease was marked by significant psychological distress: anxiety, social isolation, body image problems and feelings of stigmatisation. Several patients said they were embarrassed to talk about their illnesses, fearing a lack of social and medical understanding.  Conclusion, Male breast cancer poses multiple problems. In addition to medical treatment, a comprehensive approach including psychological support is needed. Better information for the public and healthcare professionals would enable earlier detection and more appropriate treatment, both somatic and psychological.

CALL FOR PAPERS


Paper Submission Last Date
31 - December - 2025

Video Explanation for Published paper

Never miss an update from Papermashup

Get notified about the latest tutorials and downloads.

Subscribe by Email

Get alerts directly into your inbox after each post and stay updated.
Subscribe
OR

Subscribe by RSS

Add our RSS to your feedreader to get regular updates from us.
Subscribe